远程机器人辅助腹腔镜子宫切除术治疗良性和肿瘤性疾病：30例患者的初步临床经验
Telerobotic-assisted laparoscopic hysterectomy for benign and oncologic pathologies: initial clinical experience with 30 patients.
作者信息
Marchal F, Rauch P, Vandromme J, Laurent I, Lobontiu A, Ahcel B, Verhaeghe J L, Meistelman C, Degueldre M, Villemot J P, Guillemin F
机构信息
Department of Surgery, Centre Alexis Vautrin, Av de Bourgogne, 54511, Vandoeuvre lès Nancy, France.
出版信息
Surg Endosc. 2005 Jun;19(6):826-31. doi: 10.1007/s00464-004-9122-4. Epub 2005 May 3.
BACKGROUND
Telerobotic-assisted laparoscopic attempts to provide technological solutions to the inherent limitations of traditional laparoscopic surgery. The aim of this study is to report the first experience of two teams concerning telerobotic-assisted laparoscopic hysterectomy for benign and malignant pathologies.
METHODS
This study included 14 patients at the University Hospital Saint Pierre of Brussels (Belgium) and 16 patients at the Cancer Center of Nancy (France) from September 1999 to July 2003.
RESULTS
The indications for surgery were uterine malignant diseases in 12 cases (stade I) (41%), and benign pathologies of the uterus in 18 cases (59%). Five postoperative complications (17%) occurred, none related to the robotic system.
CONCLUSION
Robotic surgery can be safely performed in gynecologic and gynecologic-oncologic surgery with no increase in complication rates. A significant advance is represented by the surgeon's ergonomic improvement.
背景
远程机器人辅助腹腔镜手术旨在为传统腹腔镜手术的固有局限性提供技术解决方案。本研究的目的是报告两个团队关于远程机器人辅助腹腔镜子宫切除术治疗良性和恶性病变的首例经验。
方法
本研究纳入了1999年9月至2003年7月在比利时布鲁塞尔圣皮埃尔大学医院的14例患者以及法国南锡癌症中心的16例患者。
结果
手术适应证为12例子宫恶性疾病（I期）（41%），18例子宫良性病变（59%）。发生了5例术后并发症（17%），均与机器人系统无关。
结论
机器人手术可在妇科和妇科肿瘤手术中安全进行，且并发症发生率无增加。外科医生的人体工程学改善是一项重大进展。
Zotero 插件